Financials data is unavailable for this security.
View more
Year on year Sonoma Pharmaceuticals Inc had revenues fall -4.05% from 13.27m to 12.74m, though the company grew net income from a loss of 5.15m to a smaller loss of 4.84m.
Gross margin | 38.17% |
---|---|
Net profit margin | -35.91% |
Operating margin | -36.49% |
Return on assets | -30.85% |
---|---|
Return on equity | -74.65% |
Return on investment | -41.88% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Sonoma Pharmaceuticals Inc fell by 692.00k. Cash Flow from Financing totalled 1.68m or 13.16% of revenues. In addition the company used 2.40m for operations while cash used for investing totalled 2.00k.
Cash flow per share | -7.25 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.24 |
---|---|
Tangible book value per share | 5.24 |
More ▼
Balance sheet in USDView more
Current ratio | 3.18 |
---|---|
Quick ratio | 2.47 |
Total debt/total equity | 0.041 |
---|---|
Total debt/total capital | 0.0394 |
More ▼